Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Black South African Patients
100%
Type 2 Diabetic Patients
100%
Advanced Glycation End Products
100%
Type 2 Diabetes Mellitus (T2DM)
75%
Race-ethnicity
50%
Carboxymethyllysine
50%
Race Groups
50%
Fluorescent AGEs
50%
Endothelial Dysfunction
50%
Serum Levels
50%
N-carboxymethyllysine
37%
Carboxyethyllysine
37%
Non-diabetic
37%
Lysine Level
25%
Markers of Endothelial Dysfunction
25%
Product Level
25%
Academic Hospital
20%
Negatively Associated
20%
Black South Africans
20%
Enzyme-linked Immunosorbent Assay (ELISA)
16%
Cross-sectional Analytical Study
12%
Pretoria
12%
South Africa
12%
Fluorescent Advanced Glycation End Products (fAGEs)
12%
Pre-diabetes (pre-DM)
8%
Black Women
8%
Spearman Correlation Coefficient
8%
Serum Markers
8%
Immunogenic
8%
Nitric Oxide Levels
8%
Logistic Regression Analysis
8%
Plasma Markers
8%
Bivariate Logistic Regression
8%
Biochemistry, Genetics and Molecular Biology
Advanced Glycation End-Product
100%
Lysine
100%
Maturity Onset Diabetes of the Young
100%
Blood Level
50%
Enzyme
16%
Cross Sectional Study
8%
Nitric Oxide
8%
Case-Control Study
8%
Blood Plasma
8%
Nursing and Health Professions
Patient with Type 2 Diabetes
50%
Advanced Glycation End Product
50%
Maturity Onset Diabetes of the Young
40%
6 N Carboxymethyllysine
30%
Lysine
30%
Study Subject
20%
Diabetes Mellitus
20%
Republic of South Africa
10%
Cross-Sectional Study
10%
